Author

Tingrong Huang

Observed names: Ting-Rong Huang, Ting-rong Huang

Institutions: Hubei University of Chinese Medicine, Huangshi Central Hospital

Observed institutions: Hubei University of Chinese Medicine, Ministry of Science and Technology of the People's Republic of China, Huangshi Central Hospital

OpenAlex ID: A5021285024

Treatment of severe COVID-19 with human umbilical cord mesenchymal stem cells

2020 · Lei Shu, Changming Niu, et al. · Stem Cell Research & Therapy · 299

Clinical characteristics and outcomes of critically ill patients with novel coronavirus infectious disease (COVID-19) in China: a retrospective multicenter study

2020 · Jianfeng Xie, Wenjuan Wu, et al. · Intensive Care Medicine · 193

PDF

Traditional Chinese medicine shenhuang granule in patients with severe/critical COVID-19: A randomized controlled multicenter trial

2021 · Shuang Zhou, Jun Feng, et al. · Phytomedicine · 62

Human Umbilical Cord Mesenchymal Stromal Cell Treatment of Severe COVID-19 Patients: A 3-Month Follow-Up Study Following Hospital Discharge

2021 · Ganzhu Feng, Lei Shi, et al. · Stem Cells and Development · 31

Intravenous Immunoglobulin Therapy for Critically Ill COVID-19 Patients With Different Inflammatory Phenotypes: A Multicenter, Retrospective Study

2022 · Yan Chen, Jianfeng Xie, et al. · Frontiers in Immunology · 19

Polyethylene glycol‐based ultrasonic‐assisted enzymatic extraction, characterization, and antioxidant activity in vitro and in vivo of polysaccharides from Lonicerae japonica leaves

2019 · Wei Wu, Tingrong Huang, et al. · Food Science & Nutrition · 17

PDF

One-year follow-up study after patients with severe COVID-19 received human umbilical cord mesenchymal stem cells treatment

2022 · Lei Shi, You Zheng, et al. · Stem Cell Research & Therapy · 12

PDF

Shenhuang granule in the treatment of severe coronavirus disease 2019 (COVID-19): study protocol for an open-label randomized controlled clinical trial

2020 · Bangjiang Fang, Wen Zhang, et al. · Trials · 10

PDF

Baidu Jieduan granules, traditional Chinese medicine, in the treatment of moderate coronavirus disease-2019 (COVID-19): study protocol for an open-label, randomized controlled clinical trial

2021 · Wen Zhang, Qin Xie, et al. · Trials · 6

PDF

Fuzheng Huayu tablets for treating pulmonary fibrosis in post-COVID-19 patients: a multicenter, randomized, double-blind, placebo-controlled trial

2025 · Fei Jing, Wei Wang, et al. · Frontiers in Pharmacology · 4

PDF

Effectiveness and Safety of Baidu Jieduan Granules for COVID-19: A Retrospective Observational Multicenter Study

2022 · Xiang-ru Xu, Wen Zhang, et al. · Chinese Journal of Integrative Medicine · 4

PDF

Meta-analysis of the effects of exercise interventions on dialysis patients with cardiac function disorders

2025 · Huizhen Liu, Ming Zhang, et al. · Frontiers in Medicine · 2

PDF

Clinical predictive risk factors prolonged the duration of SARS-CoV-2 clearance in 279 moderate COVID-19 patients

2021 · Xinxin Wu, Shuang Zhou, et al. · Medicine · 1

Invasive Mechanical Ventilation May Be an Important Factor of Mortality in Severe/Critical COVID-19 Pneumonia: A Retrospective Cohort Study

2020 · Jing Wei, Lei Shi, et al. · Research Square · 1

PDF

Clinical Characteristics and Outcomes of Critically Ill Patients with Novel Coronavirus Infectious Disease (COVID-19) In China: A Retrospective Multicenter Descriptive Study

2020 · Jianfeng Xie, Wenjuan Wu, et al. · SSRN Electronic Journal

我國與歐盟東擴國家貿易因素之實證探討-Panel Data之應用

2008 · 黃亭榕, Tingrong Huang

[Clinical study on round-sharp needle therapy combined with massage for prolapse of lumbar intervertebral disk].

2006 · Yi-Yu Peng, Yi-Sheng Huang, et al. · PubMed

Works count: 17

Citation count: 660

H-index: 8

I10-index: 8